Minerva Neurosciences
NERV
84 hedge funds and large institutions have $200M invested in Minerva Neurosciences in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 6 closing their positions.
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
24% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 25
2% more funds holding
Funds holding: 82 → 84 (+2)
0.14% more ownership
Funds ownership: 9.42% → 9.56% (+0.14%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
45% less capital invested
Capital invested by funds: $367M → $200M (-$166M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$4.49M |
| 2 |
NLVP
New Leaf Venture Partners
New York
|
+$2.68M |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$1.41M |
| 4 |
Renaissance Technologies
New York
|
+$1.36M |
| 5 |
Morgan Stanley
New York
|
+$866K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MWNA
Marshall Wace North America
New York
|
-$3.07M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$2.58M |
| 3 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$1.76M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$1.36M |
| 5 |
JG
Jefferies Group
New York
|
-$952K |
NERV Hedge Fund Activity: Q4 2018 in Review
84 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2018, worth a combined $200M — down 45% from $367M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new NERV positions and 6 closed out — a net gain of 2 holders — while 31 added to existing stakes and 25 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $4.49M. The largest seller was Marshall Wace North America, cutting an estimated $3.07M.
- 84 institutional investors held Minerva Neurosciences (NERV) as of Q4 2018, up from 82 in Q3 2018.
- Funds reported $200M of Minerva Neurosciences stock for Q4 2018, down 45% quarter-over-quarter.
- 8 funds opened new Minerva Neurosciences positions in Q4 2018 and 6 closed out, a net change of +2 holders.
- The largest Minerva Neurosciences buyer in Q4 2018 was Wellington Management Group, an estimated $4.49M added.
- The largest Minerva Neurosciences seller in Q4 2018 was Marshall Wace North America, an estimated $3.07M sold.
Based on aggregated 13F filings for Q4 2018.